Observational studyWorld journal of urology2025
Donor site morbidity and impact on oral health following buccal mucosal graft harvesting for urethroplasty: a prospective study.
Observational study in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate patient-reported oral health and pain and buccal donor site complications in adults who underwent BMG harvesting utilizing two validated questionnaires. MATERIALS AND
methodsAn ethics-approved prospective observational study was conducted among a cohort of 40 adults who had a BMG urethroplasty between June 2020 and October 2021. All cases were performed by one fellowship-trained genitourinary reconstructive surgeon. Oral health was appraised before and after BMG harvesting via the validated Oral Impacts of Daily Performance (OIDP) questionnaire. Post-operative pain at the BMG donor site was assessed by administering the Visual Analogue Scale for pain (VAS) both pre-and post-operatively. Statistical analysis was undertaken to identify risk factors for increased post-operative pain and decreased oral health.
resultsThe cohort included sub-meatal, penile, bulbar, and pan-urethral strictures. Most cases (36/40) were a primary urethroplasty, but 4 cases were a re-do urethroplasty. Only 5 participants (12.5%) experienced complication(s) at the donor site such as bleeding (2/40, 5%), infection (1/40, 2.5%), hyper granulation tissue (1/40, 2.5%), and long-term difficulty with mouth opening (3/40, 7.5%). Most participants (32/40, 80%) had at least one daily oral performance affected by BMG harvesting. Eating, speaking, and cleaning teeth were the most impacted domains. However, there was no statistically significant decrease in oral health at either 3- or 6 months post-BMG harvesting (p < 0.05). Almost all participants (38/40, 95%) reported no pain at the donor site before BMG harvesting. Pain at the donor site peaked at 1 week post-operatively (28/40, 70%), but the majority were pain-free by 3 months post-BMG harvesting (35/40, 87.5%).
conclusionBMG harvesting is an effective means of procuring a suitable graft for urethroplasty. Whilst pain at the donor site is experienced in the immediate post-operative period, long-term pain is a rare complication. Overall oral health is not detrimentally impacted by BMG harvesting.
Indexed as
Identifiers
40897855What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.